X

Health Care

Bio-Path’s stock tanks as company delivers loss for Q1

Bio-Path Holdings Inc.’s (NASDAQ: BPTH) shares were down 3.2% in morning hours on Thursday after the company reported its first…

Titan Pharmaceuticals posts wider-than-expected Q1 loss

Titan Pharmaceuticals (TTNP) reported a wider loss in the first quarter of 2019 due to lower revenues and higher operating…

Johnson & Johnson set to revitalize pharma biz; eyes ‘above-market’ growth

Drug maker Johnson & Johnson (NYSE: JNJ) is all set to embark on an extensive program to strengthen the product…

Aurora Cannabis’ net loss widens in Q3

Like last quarter, Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB) delayed its third-quarter earnings today. The company reported a loss…

Aurinia Pharmaceuticals loss narrowed in Q1; AURORA trial on track

Aurinia Pharmaceuticals (NASDAQ:AUPH / TSX:AUP) narrowed its loss in the first quarter. Post the Q1 results, stock rose 2% in…

Tilray Q1 loss widens, meets estimates

Tilray (TLRY) reported a wider loss in the first quarter of 2019 due to higher operating costs and expenses. The…

Earnings: Agilent stock falls on Q2 earnings miss, weak guidance

Earnings of Agilent Technologies (Nasdaq: A), which manufactures instruments used in medical laboratories, increased in the second quarter but missed…

Solid Biosciences tumbles 38% to hit historic low

Shares of Solid Biosciences Inc. (NASDAQ: SLDB) opened 38% lower on Tuesday after the company said in its first-quarter results…

Earnings: Catabasis Q1 loss narrows on lower expenses, beats estimates

Catabasis Pharmaceuticals (Nasdaq: CATB) reported a narrower net loss for the first quarter of 2019. The improvement in the bottom…

InspireMD Q1 revenues plunge on third-party equipment failure

Israel-based medical device company InspireMD (NYSE: NSPR) reported a first-quarter loss of $3.82 per share, much wider than the loss…